Logo image of UROY

URANIUM ROYALTY CORP (UROY) Stock Fundamental Analysis

NASDAQ:UROY - Nasdaq - CA91702V1013 - Common Stock - Currency: USD

2.21  -0.04 (-1.78%)

After market: 2.25 +0.04 (+1.81%)

Fundamental Rating

2

Taking everything into account, UROY scores 2 out of 10 in our fundamental rating. UROY was compared to 213 industry peers in the Oil, Gas & Consumable Fuels industry. While UROY seems to be doing ok healthwise, there are quite some concerns on its profitability. UROY does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year UROY has reported negative net income.
UROY had a negative operating cash flow in the past year.
UROY had negative earnings in 4 of the past 5 years.
UROY had a negative operating cash flow in each of the past 5 years.
UROY Yearly Net Income VS EBIT VS OCF VS FCFUROY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.36%, UROY is doing worse than 67.61% of the companies in the same industry.
UROY has a worse Return On Equity (0.36%) than 66.20% of its industry peers.
Industry RankSector Rank
ROA 0.36%
ROE 0.36%
ROIC N/A
ROA(3y)-0.67%
ROA(5y)-1.53%
ROE(3y)-0.79%
ROE(5y)-1.61%
ROIC(3y)N/A
ROIC(5y)N/A
UROY Yearly ROA, ROE, ROICUROY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -5 -10 -15

1.3 Margins

Looking at the Profit Margin, with a value of 4.65%, UROY is in line with its industry, outperforming 42.72% of the companies in the same industry.
UROY's Gross Margin of 63.78% is fine compared to the rest of the industry. UROY outperforms 72.30% of its industry peers.
Industry RankSector Rank
OM N/A
PM (TTM) 4.65%
GM 63.78%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
UROY Yearly Profit, Operating, Gross MarginsUROY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

More info and screens

6

2. Health

2.1 Basic Checks

UROY does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, UROY has more shares outstanding
The number of shares outstanding for UROY has been increased compared to 5 years ago.
UROY has a better debt/assets ratio than last year.
UROY Yearly Shares OutstandingUROY Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
UROY Yearly Total Debt VS Total AssetsUROY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

UROY has an Altman-Z score of 193.03. This indicates that UROY is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of UROY (193.03) is better than 99.53% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that UROY is not too dependend on debt financing.
UROY has a better Debt to Equity ratio (0.00) than 84.04% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 193.03
ROIC/WACCN/A
WACC8.92%
UROY Yearly LT Debt VS Equity VS FCFUROY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

UROY has a Current Ratio of 216.58. This indicates that UROY is financially healthy and has no problem in meeting its short term obligations.
UROY has a Current ratio of 216.58. This is amongst the best in the industry. UROY outperforms 100.00% of its industry peers.
A Quick Ratio of 16.29 indicates that UROY has no problem at all paying its short term obligations.
UROY's Quick ratio of 16.29 is amongst the best of the industry. UROY outperforms 97.65% of its industry peers.
Industry RankSector Rank
Current Ratio 216.58
Quick Ratio 16.29
UROY Yearly Current Assets VS Current LiabilitesUROY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

0

3. Growth

3.1 Past

UROY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -89.20%.
The Revenue for UROY has decreased by -47.81% in the past year. This is quite bad
EPS 1Y (TTM)-89.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-148.67%
Revenue 1Y (TTM)-47.81%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-99.97%

3.2 Future

The Earnings Per Share is expected to decrease by -32.80% on average over the next years. This is quite bad
The Revenue is expected to decrease by -2.88% on average over the next years.
EPS Next Y-90.47%
EPS Next 2Y-49.6%
EPS Next 3Y-17.02%
EPS Next 5Y-32.8%
Revenue Next Year-59.28%
Revenue Next 2Y-36.86%
Revenue Next 3Y-39.63%
Revenue Next 5Y-2.88%

3.3 Evolution

UROY Yearly Revenue VS EstimatesUROY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 10M 20M 30M 40M
UROY Yearly EPS VS EstimatesUROY Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 0 0.05 -0.05

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Forward Price/Earnings Ratio is negative for UROY. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
UROY Price Earnings VS Forward Price EarningsUROY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
UROY Per share dataUROY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

UROY's earnings are expected to decrease with -17.02% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-49.6%
EPS Next 3Y-17.02%

More info and screens

0

5. Dividend

5.1 Amount

UROY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

URANIUM ROYALTY CORP

NASDAQ:UROY (5/30/2025, 8:00:01 PM)

After market: 2.25 +0.04 (+1.81%)

2.21

-0.04 (-1.78%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)03-06 2025-03-06
Earnings (Next)09-10 2025-09-10
Inst Owners25.1%
Inst Owner Change6.1%
Ins Owners2.18%
Ins Owner ChangeN/A
Market Cap295.34M
Analysts77.5
Price Target3.45 (56.11%)
Short Float %12.74%
Short Ratio4.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-49.5%
Min EPS beat(2)-100%
Max EPS beat(2)0.99%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-51.79%
Min Revenue beat(2)-99.97%
Max Revenue beat(2)-3.62%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.18%
PT rev (3m)-32%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-133.33%
EPS NY rev (1m)0%
EPS NY rev (3m)144.47%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-18.04%
Revenue NY rev (3m)-25.92%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 17.63
P/FCF N/A
P/OCF N/A
P/B 1.37
P/tB 1.37
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-0.26
FCFYN/A
OCF(TTM)-0.2
OCFYN/A
SpS0.13
BVpS1.61
TBVpS1.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.36%
ROE 0.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 4.65%
GM 63.78%
FCFM N/A
ROA(3y)-0.67%
ROA(5y)-1.53%
ROE(3y)-0.79%
ROE(5y)-1.61%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 216.58
Quick Ratio 16.29
Altman-Z 193.03
F-Score3
WACC8.92%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-89.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-148.67%
EPS Next Y-90.47%
EPS Next 2Y-49.6%
EPS Next 3Y-17.02%
EPS Next 5Y-32.8%
Revenue 1Y (TTM)-47.81%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-99.97%
Revenue Next Year-59.28%
Revenue Next 2Y-36.86%
Revenue Next 3Y-39.63%
Revenue Next 5Y-2.88%
EBIT growth 1Y-114.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-87.3%
EBIT Next 3Y-0.49%
EBIT Next 5Y-42.35%
FCF growth 1Y-154.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-93.38%
OCF growth 3YN/A
OCF growth 5YN/A